Bu videoda bilim adamları nasıl yaşayan ve çoğalan sentetik hücre yapmayı başardığını görebilirsiniz. Bu şekilde yeni ilaçlar ve aşılar elde etmeyi düşünüyorlar.
Barrister, peer and Vice-President of the Patients Association Baroness Helena Kennedy has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7424051-helena-kennedy-astellas-debate/
George Freeman MP, the Minister for Life Sciences, will give the keynote address at the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
George Freeman’s keynote address will outline the Government’s aim to develop, assess and adopt new drugs, devices and diagnostics as we move towards 21st century, personalised healthcare.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7423951-george-freeman-astellas-debate/
At the home of the world-famous Monte Carlo Rally and on the Col de Turini, site of some of racing’s most memorable moments, Groupe Renault today announced plans for a new Alpine sports car, and unveiled the Alpine Vision show car.
“Motorsports and sports cars are deeply rooted in the DNA of Groupe Renault,” Groupe Renault Chairman and CEO Carlos Ghosn said. “Earlier this month we announced our return to Formula One with a Renault team, and today we are announcing Alpine. This is an exciting next step in our strategy to leverage talent and technology between road and track, and we look forward to reaching new customers in the sport premium cars segment.”
The show car Alpine Vision combines sensual design with outstanding agility, true to the great Alpine A110 Berlinette loved and admired by enthusiasts around the world. Alpine Vision is powered by a new 4 cylinder turbocharged engine, built by experts at Renault Sport, and its low weight will allow the car to achieve 0 to 100 km/h in less than 4.5 seconds - the target for the future production model.
Alpine will be managed by a small team of passionate experts within Groupe Renault, with one sole mission – to meet and exceed the expectations of the demanding sport premium customer. Michael van der Sande will lead as Alpine managing director, and Antony Villain will head Alpine design.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7762651-groupe-renault-unveils-plans-for-alpine/
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7092251-fda-approve-s-exact-sciences-cologuard-screening-test-colorectal-cancer/
Professor Lionel Tarassenko, CBE, Head of Engineering at the University of Oxford and Fellow of the Royal Academy of Engineering and the Academy of Medical Sciences, has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
As the worlds of science and technology come together, the 2015 Astellas Innovation Debate, organised and funded by Astellas, will discuss recent breakthroughs in genetic medicine and smart technology, and what they mean for our health.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7432051-lionel-tarassenko-astellas-debate/
Advanced technology has the power to transform healthcare, a world leader in the field of genomicsDr Leroy Hood, has said ahead of the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7430051-dr-leroy-hood-astellas-debate/
Bu videoyu seyrederken dehşete düştüm, tanrı evrimi kanıtlamak için hem şempanzelerin hem de insanların DNA'larına 16 yerden ERV (virüsten kaynaklanan hata) yerleştirmiş. Buna inanmak mı daha kolay, yoksa bu hataların ortak atamızdan her iki türe de geçtiği mi akla daha yakın. İzleyin, olasılıkları görün ve kendiniz karar verin.
http://materyalistceseyler.wordpress.com/
Personalised Medicine is the future of cancer treatment, but it presents major challenges for doctors and health services, the President of the European Society of Medical Oncology has said. Professor Rolf Stahel was speaking ahead of the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7430351-professor-rolf-stahel-astellas-debate/
Sentetik biyoloji, bilim dünyasında giderek önem kazanmaya başlayan bir alan haline geldi. İngiltere hükümeti de bu alanı öncelikleri arasına aldı. Bu yeni bilim dalı, daha önce doğada varolmayan canlı organizmayı tasarlayıp yaratmayı amaçlıyor. Çalışmayı yürüten bilim insanları, bu sıradışı teknolojiyle yeni yakıt ve ilaç türleri için büyük bir fırsat doğacağı görüşünde. Ancak çevreciler, bu yeni organizmaların doğaya yayılmasının risklerine dikkat çekiyor.
http://www.bbc.co.uk/turkce/multimedya/2012/03/120329_dg_synthetic_biology.shtml
BloodCenter of Wisconsin’s Diagnostic Laboratories today announced the availability of a comprehensive cancer mutation HemeOnc Panel using next generation sequencing (NGS) technology. The NGS panel developed by BloodCenter of Wisconsin is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7363151-bloodcenter-of-wisconsin-launches-next-generation-sequencing-hemeonc-panel/
Bu videoda Celal Şengör evrim teorisinin 18 yüzyılda nasıl yavaş yavaş geliştiğini, hangi bilim adamların katkıda bulunduğunu ve Darwin'in bunları nasıl birleştirdiğini örnekleriyle beraber çok hoş bir şekilde anlatıyor.
